A prospective study on assessment of risk factors and impact of patient counselling in health-related quality of life of patients with coronary artery diseases

Neenu Babu, Shamna C., Sreelakshmi V. S., Philip John Sebastian, Prasobh G. R., Nitin Manohar R.


Background: Cardiovascular disease is the most frequent cause of morbidity and mortality throughout the world. The aim of the study was to determine assessment of risk factors and impact of patient counseling in health-related quality of life of the patient.

Method: This was a prospective observational study conducted in the department of cardiology. A suitably designed standard SF-36 questionnaire was given to all patients enrolled in the study before and after counseling. All information relevant to the study were collected in suitably designed proforma from case records and discussions conducted with the patients and bystanders during ward rounds. Proper counseling was given to patients and bystanders and the score was analyzed using SAS descriptive analysis.

Result: The most common risk factors encountered in the study are diabetes mellitus, hypertension, dyslipidemia, irregular exercise, smoking, alcoholism, obesity and family history. The health-related quality of life of the patients were assessed, a total of 67 patients QOL was improved after counseling and 27 patients with no improvement. We found that patient counseling was effective for majority of patients.

Conclusions: We can conclude that the role of clinical pharmacist has a significant role in improving the health-related quality of life of patients through proper counseling. And more than half of the patients have a modifiable risk factor which can be managed through lifestyle modifications.


Coronary artery disease, Short form-36, Quality of life

Full Text:



Fausto. The Heart. In: Robbins, Cotran Kumar. Robbins and Cotran pathological Basis of Disease. 5th edition. Philadelphia. Saunders International edition. 2005:524-8.

Mc Robbie D. Coronary heart disease. In: Roger Walker, eds. Clinical Pharmacy and Therapeutics, 5th edition. London, Elsevier. 2012;312-5.

O’brien C. Cardiovascular drugs. In: Brunton LB, Lazo JS, Parker KL, eds. Goodman and Gillmans textbook for therapeutics. 11th edition. Newyork, Mc Grawhill. 2005;502-19.

Bonow RO. Coronary artery diseases. In: Ziper DP, Libby P, Bonow RO, Braunwald E. Braunwald’s Heart Disease-A Text Book of Cardiovascular Medicine. 7th edition. Philadelphia. Elsevier. 2004;01-10.

Ferro A. Ischemic heart disease. In: Ritter JM, Lewus LD, Mant TGK, ferro A, eds. A textbook of clinical pharmacology and therapeutics. 5th edition. Great Britian. Hodder education. 2008;196-210.

Yee GC. The cardiovascular system. In: Dipiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM. Pharmacotherapy: A Pathophysiologic approach. 6th edition. New York. McGraw-Hill medical publishing division. 2005;292-93.

Fuster V. Atherosceloris. In: Alexander RW, Rourke RAO, Roberts R, King SB, Nash IS, Drystowsky EN. Hurt’s: The Heart. 2nd ed. Mc Graw hill. Medical publishing division US. 2285.

Damjanov I. The Heart. In: Harsh Mohan. Text Book of Pathology, 7th ed. New Delhi, Jaypee brothers’ medical publishers. 2015;393-95.

Kumar L, Prakash A, Gupta SK. Assessment of economic burden and Quality of life in stable coronary artery disease patients. IJMS. 2019;10:26-9.

Lian CW, Yein LP, Yaman K, Wahab RA. A Preliminary Study on the Prevalence of Cardiovascular Disease Risk Factors in Selected Rural Communities in Samarahan and Kuching Division, Sarawak, Malaysia. Malaysian J Med Sci. 2011;18(2):59-66.

Zachariah TG, Subramanyam K, Pooja M, Vinayak J. Kempaller. Drug utilization study in ischemic heart disease in a tertiary care hospital, Mangalore, India. Int J Bio Clin Pract. 2017;6(7):1799-1805.

Zengin E, Bickel C, Schnabel RB. Risk factors of Coronary Artery Disease in secondary prevention- Results from the Atherogene- study. Plos one. 2015;10(7):e0131434.

Mukhopadhyay S, Kumar M, Yusuf J, Gupta VK, Tyagi S. Risk factors and angiographic profile of coronary slow flow (CSF) phenomenon in North Indian population: An observational study. IHJ. 2018;70:405-9.

Parsa A, Sadeghi M, Roghahi F, Golshahi J, Khani A, Yazdekhasti S et al. Effects of Changes in Myocardial Dysfunction on Quality of Life in Patients Undergoing Coronary Angioplasty After Cardiac Rehabilitation. Iranian Heart J. 2018;19(1):52-60.

Chauhan PA, Atul Trivedi. Study of prescription and behavior in patients with coronary heart disease about risk factors and life style modification in a tertiary care hospital, Bhavnagar. Int j comm med public health. 2019;6(4):1549-53.

Shah AD, Langenberg C, Rapsomaniki E, Denaxas S, Pujades MR, Gale CP, Deanfield J et al. Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1.9 million people. Lancet Diabetes Endocrinol. 2015;3:105-13.

Dodani S, Sharma GK. Presence of coronary artery disease in diabetic and non-diabetic South Asian immigrants. IHJ. 2018;70:50-5.

Duenas M, Salazar A, Ojeda B, Failde I. Health Related Quality of Life in Coronary Patients. Preventive Medicine Public Health Dpt. University of Cadiz, Spain. 2012.

Morys JM, Pachalsk M, Bellvone J, Gruchala M. Quality of life in patients with coronary heart disease after Myocardal infarction and with Ischemic heart failure. Arch Med Sci. 2014;12(2): 326-33.

Zhang J-P, Pozuelo L, Brennan DM, Hoar B, Hoogwerf BJ. Association of SF-36 with Coronary Artery Disease, Risk factors and mortality: A Pre-CIS Study. Prev Cardiol. 2010;13:122-9.